Treatment Tolerability and Toxicity of Postoperative Proton Beam Therapy for Gynecologic Malignancies: Results of the Prospective Phase 2 APROVE Trial.
05/09/2023
/
Publications
This study by the Heidelberg group reported clinical outcomes of 25 patients with uterine cervical or endometrial cancer treated with postoperative PBT. Proton...
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
01/03/2024
/
Publications
The same study as above also reported results of QoL and patient-reported outcomes. QoL status was markedly impaired at baseline but significantly (p = 0.036)...
Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer.
01/03/2024
/
Publications
This study reported results of patients with uterine cancer treated with PT (n=22) and IMRT (n=45). When comparing gynecologic-specific subset of PRO-CTCAE, PT...
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.
01/03/2024
/
Publications
This report presented the results of patients with non-CNS malignancies treated in the UK proton overseas program. Four hundred and ninety-five patients were...
Acute and long-term toxicity of whole pelvis proton radiation therapy for definitive or adjuvant management of gynecologic cancers.
16/05/2023
/
Publications
/
Toxicity
This study reported outcomes of 23 patients with gynecologic malignancies treated with PBSPRT. 12 (52.2%) patients had uterine cancer, 10 (43.5%) cervical, and...
Quality-of-life evaluations in children and adolescents with Ewing sarcoma treated with pencil-beam-scanning proton therapy.
12/01/2023
/
Publications
/
Pencil Beam Scanning - PBS
This study investigated the QoL of patients with Ewing sarcoma treated with PBS-PT. A PEDQOL questionnaire evaluating eight different domains was filled by the...
Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma-Tumor and Treatment Characteristics and Early Clinical Outcomes.
16/01/2023
/
Publications
This study reported early outcomes of 21 adult pelvic Ewing sarcoma treated with PT (n=18 primary disease) to a total dose of 45-60 GyRBE and with carbon ion (n...
A systematic review and meta-analysis of radiotherapy and particle beam therapy for skull base chondrosarcoma: TRP-chondrosarcoma 2024.
06/05/2024
/
Publications
/
Survival
Based on 21 original studies, this meta-analysis reported a significant association of PT with a superior 5-year OS rate compared to three-dimensional conformal...
The Use of Proton and Carbon Ion Radiation Therapy for Sarcomas.
06/05/2024
/
Publications
/
Reirradiation
. A review article by the MGH group summarized clinical data of particle therapy for chordoma, chondrosarcoma, Ewing sarcoma, osteosarcoma, retroperitoneal...
Proton beam therapy for clival chordoma: Optimising rare cancer treatments in Australia.
06/05/2024
/
Publications
/
Quality assurance
This review evaluated clinical evidence of surgery, photon-based radiotherapy and proton therapy for clival chordoma. The authors stated that contemporaneous...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.